Aneuploidy is the presence of an abnormal number of chromosomes in a cell, either one too many or one too few. It results from nondisjunction, the failure of chromosomes to separate properly during cell division. If you’re trying to identify which statements about aneuploidy are true (a common exam question), the key facts below will help you distinguish correct claims from false ones.
Nondisjunction Is the Primary Cause
Aneuploidy happens when chromosomes fail to separate during anaphase, a stage of cell division. This error, called nondisjunction, can occur during meiosis I, meiosis II, or even mitosis. The timing of the error determines how many resulting cells are affected.
When nondisjunction occurs in meiosis I, the paired chromosomes (tetrads) fail to pull apart. This produces two daughter cells with an extra chromosome (n+1) and two with a missing chromosome (n-1) after meiosis II completes. All four resulting sex cells are abnormal.
When the error occurs in meiosis II, sister chromatids fail to separate. Because meiosis I proceeded normally, only two of the four daughter cells are aneuploid (one n+1 and one n-1). The other two are completely normal. This distinction between meiosis I and meiosis II errors is a frequently tested concept: meiosis I errors affect all four gametes, while meiosis II errors affect only half.
Only Three Autosomal Trisomies Survive to Birth
Of the 22 pairs of autosomes (non-sex chromosomes) in humans, trisomy is compatible with live birth for only three: chromosome 21 (Down syndrome), chromosome 18 (Edwards syndrome), and chromosome 13 (Patau syndrome). Every other autosomal trisomy is so disruptive to development that the pregnancy ends in miscarriage, often before the person even knows they’re pregnant. Trisomy 16, for example, is the most common trisomy found in miscarriage tissue but is never seen in live births.
Even among the three survivable trisomies, outcomes vary dramatically. Down syndrome is the only one where individuals routinely survive into adulthood. Trisomy 18 occurs in roughly 1 in 6,670 live births, and trisomy 13 in about 1 in 12,340. Both carry severe health complications and significantly shortened life expectancy.
Autosomal Monosomy Is Always Lethal
A common true/false distinction: while some trisomies are viable, no autosomal monosomy (missing one copy of a non-sex chromosome) has ever been identified even among spontaneous abortions. This means autosomal monosomies are lethal so early that the embryo cannot develop at all. The only monosomy compatible with life in humans is monosomy X, also called Turner syndrome, which involves sex chromosomes rather than autosomes. Even then, more than 99% of fetuses with a 45,X karyotype miscarry before 28 weeks.
Sex Chromosome Aneuploidy Is More Survivable
Sex chromosome aneuploidies are generally better tolerated than autosomal ones. Turner syndrome (one X chromosome, no second sex chromosome) occurs in approximately 25 to 50 per 100,000 live female births. About half of cases show the classic 45,X karyotype, while the other half involve mosaicism or structural X chromosome abnormalities.
Klinefelter syndrome (47,XXY) is even more common, estimated at 1 in 500 to 1 in 1,000 live male births. Around 80% of cases have the standard 47,XXY karyotype, with the remaining 20% showing mosaic patterns or additional structural variants. Many people with Klinefelter syndrome are not diagnosed until adulthood, if at all, because the symptoms can be mild. This relatively mild presentation is a major reason sex chromosome aneuploidies are more survivable: the X-inactivation system that normally silences one X chromosome in females provides a buffer against extra copies.
Aneuploidy Causes Most First-Trimester Miscarriages
Roughly half of all first-trimester miscarriages are caused by fetal chromosomal abnormalities. In one large study of 832 miscarriage samples, 44% showed chromosomal abnormalities, and of those abnormal cases, 84% were specifically aneuploidies rather than other types of chromosomal errors. This makes aneuploidy the single most common biological cause of early pregnancy loss.
Maternal Age Sharply Increases Risk
The risk of fetal aneuploidy rises steeply with maternal age. A Danish study of more than 500,000 pregnancies quantified the risk of trisomy 21 across age groups. For women aged 20 to 29, the prevalence was about 0.10%. By ages 35 to 39, it climbed to 0.62%, roughly six times higher. For women 40 to 44, it jumped to 2.14%, more than 20 times the baseline. And for women 45 and older, the rate reached 3.22%.
This age-related increase happens because egg cells sit suspended in meiosis for decades. The older the egg, the more likely the proteins holding chromosomes together have degraded, increasing the chance of nondisjunction. Sperm cells, which are continuously produced, contribute far less to age-related aneuploidy risk.
Aneuploidy Is a Hallmark of Cancer
Aneuploidy is not limited to reproductive errors. Cancer cells derived from solid tumors almost invariably display abnormal chromosome numbers. This happens through chromosomal instability, a condition where dividing cancer cells frequently missort their chromosomes. The ongoing reshuffling creates genetic diversity within a tumor, allowing some cells to develop drug resistance, evade the immune system, or acquire the ability to spread to other organs.
Increased chromosomal instability has been linked to metastatic progression in prostate, pancreatic, breast, colorectal, and kidney cancers. The relationship works in both directions: aneuploidy can drive cancer progression, and the DNA repair defects common in cancer cells make further aneuploidy more likely. This self-reinforcing cycle helps explain why advanced cancers often have wildly abnormal karyotypes with dozens of chromosomal changes.
Prenatal Screening Can Detect Common Aneuploidies
Non-invasive prenatal testing (NIPT) analyzes fragments of fetal DNA circulating in the mother’s blood. For trisomy 21, the detection rate exceeds 99% with a false positive rate below 1%. Sensitivity is lower for rarer conditions: above 85% for trisomy 18 and above 70% for trisomy 13. NIPT is a screening tool, not a diagnostic one, so a positive result is typically confirmed through amniocentesis or chorionic villus sampling before any clinical decisions are made.